Boehringer facing more than 2,000 U.S. lawsuits over blood thinner

[Reuters] – German drugmaker Boehringer Ingelheim said on Thursday it is facing more than 2,000 lawsuits in the United States over claims its blockbuster drug Pradaxa, the first in a new class of stroke prevention pills, caused severe and fatal bleeding. more

View todays social media effects on BMY

View the latest stocks trending across Twitter. Click to view dashboard

See who Bristol is hiring next, click here to view